scispace - formally typeset
P

Peter Willadsen

Researcher at Commonwealth Scientific and Industrial Research Organisation

Publications -  75
Citations -  5659

Peter Willadsen is an academic researcher from Commonwealth Scientific and Industrial Research Organisation. The author has contributed to research in topics: Antigen & Tick. The author has an hindex of 37, co-authored 75 publications receiving 5394 citations. Previous affiliations of Peter Willadsen include Cooperative Research Centre & University of Queensland.

Papers
More filters
Journal Article

Immunologic control of a parasitic arthropod. Identification of a protective antigen from Boophilus microplus.

TL;DR: Microgram amounts of the responsible tick gut Ag are able to induce effective protection in cattle against the parasite, as shown by the decreased survival of ticks on vaccinated cattle and a reduction in engorgement weights and egg laying capacity of the survivors.
Journal ArticleDOI

Peritrophic matrix proteins.

TL;DR: This review summarizes emerging knowledge of the main protein constituents of the peritrophic matrix and concludes with speculation about the biological functions of the proteins in this matrix.
Journal ArticleDOI

Commercialisation of a recombinant vaccine against Boophilus microplus.

TL;DR: The vaccine has been tested in the field, has been taken through the full registration process and is now in commercial use in Australia, and a related development has occurred in Cuba.
Journal ArticleDOI

A ten-year review of commercial vaccine performance for control of tick infestations on cattle.

TL;DR: Commercial tick vaccines for cattle based on the Boophilus microplus Bm86 gut antigen have proven to be a feasible tick control method that offers a cost-effective, environmentally friendly alternative to the use of acaricides.
Journal ArticleDOI

Anti-tick vaccines.

TL;DR: There is now abundant evidence that vaccination with defined protein antigens is able to induce significant immunity to tick infestation, but under most circumstances the use of a tick vaccine as the single, stand alone control technology is likely to require more efficacious vaccines than those currently available.